Rapid Immune Responses to a Botulinum Neurotoxin Hc Subunit Vaccine throughIn VivoTargeting to Antigen-Presenting Cells

Botulinum Neurotoxin Vaccines:  Past history and recent developments

(2014) Janice M. Rusnak et al.   Human vaccines & immunotherapeutics

Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation

(2010) K. Birkholz et al.   BLOOD

Immune Complex-Mediated Enhancement of Secondary Antibody Responses

(2010) C. L. Goins et al.   JOURNAL OF IMMUNOLOGY

Comparison of the primary rat spinal cord cell (RSC) assay and the mouse bioassay for botulinum neurotoxin type A potency determination

(2010) Sabine Pellett et al.   JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS

Fc receptor-targeted mucosal vaccination as a novel strategy for the generation of enhanced immunity against mucosal and non-mucosal pathogens

(2009) Edmund J. Gosselin et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

FCGR3Apolymorphism story: a new piece of the puzzle

(2009) Guillaume Cartron   LEUKEMIA & LYMPHOMA

Botulism and vaccines for its prevention

(2009) Leonard A. Smith   VACCINE

Protection with a recombinant Hc ofClostridium Botulinumneurotoxin serotype A fromEscherichia colias an effective subunit vaccine

(2008) Yun-Zhou Yu et al.   IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY

The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells

(2008) Godwin Nchinda et al.   JOURNAL OF CLINICAL INVESTIGATION

UpGene: Application of a Web-Based DNA Codon Optimization Algorithm

(2004) Wentao Gao et al.   BIOTECHNOLOGY PROGRESS